75 result(s) found
M&T Bank (MTB) Expands nCino Partnership for AI Credit Solution
https://www.zacks.com/stock/news/2275627/m-t-bank-mtb-expands-ncino-partnership-for-ai-credit-solution?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2275627
May 17, 2024 - M&T Bank (MTB) is integrating a continuous credit monitoring solution by nCino to strengthen its capabilities in order to manage credit risk better.
0
Want Better Returns? Don?t Ignore These 2 Consumer Discretionary Stocks Set to Beat Earnings
https://www.zacks.com/stock/news/2227782/want-better-returns-don-t-ignore-these-2-consumer-discretionary-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2227782
Feb 19, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
0
HCA Healthcare (HCA) Drives Efficiency With New Outpatient Model
https://www.zacks.com/stock/news/2231234/hca-healthcare-hca-drives-efficiency-with-new-outpatient-model?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2231234
Feb 23, 2024 - HCA Healthcare's (HCA) Sarah Cannon Cancer Institute adopts a new outpatient model for CAR T-cell therapy patients.
0
Wall Street Breakfast: Flush With Cash
https://seekingalpha.com/article/4673379-wall-street-breakfast-flush-cash?source=feed_tag_wall_st_breakfast
Feb 26, 2024 - This article discusses bigwigs selling shares and accumulating cash, Samsung's Galaxy Ring, Google disclosing Microsoft's 2018 bid to sell Bing to Apple, and AT&T's $5 outage credit.
0
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley
https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353
Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
0
W&T (WTI) Reports Q4 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2236364/w-t-wti-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2236364
Mar 05, 2024 - While the top- and bottom-line numbers for W&T (WTI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Want Better Returns? Don?t Ignore These 2 Consumer Discretionary Stocks Set to Beat Earnings
https://www.zacks.com/stock/news/2235902/want-better-returns-don-t-ignore-these-2-consumer-discretionary-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2235902
Mar 05, 2024 - The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
0
Earnings Estimates Rising for T. Rowe (TROW): Will It Gain?
https://www.zacks.com/stock/news/2236197/earnings-estimates-rising-for-t-rowe-trow-will-it-gain?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2236197
Mar 05, 2024 - T. Rowe (TROW) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
Allogene (ALLO) Inks Deal With Arbor Bio for CRISPR Technology
https://www.zacks.com/stock/news/2240226/allogene-allo-inks-deal-with-arbor-bio-for-crispr-technology?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2240226
Mar 13, 2024 - Allogene (ALLO) intends to combine its next generation AlloCAR T platform with Arbor Biotechnologies' proprietary CRISPR gene therapy technology to develop therapies for autoimmune diseases.
0
JPST: Good Short-Term Income Fund, But Not A Buy At These Levels
https://seekingalpha.com/article/4678163-jpst-good-short-term-income-fund-but-not-a-buy-at-these-levels?source=feed_tag_etf_portfolio_strategy
Mar 14, 2024 - JPMorgan Ultra-Short Income ETF is quite similar to T-bills, with slightly higher risk, and slightly higher returns. Read more on JPST ETF here.
0